|
Volumn 34, Issue 5, 2002, Pages 1691-1692
|
Steroids may compromise quality of life of renal transplant recipients on a tacrolimus-based regimen
a b c d a c d a,e |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
CORTICOSTEROID;
IMMUNOSUPPRESSIVE AGENT;
ADULT;
CONFERENCE PAPER;
CONTROLLED STUDY;
DISTRESS SYNDROME;
EMOTION;
FEMALE;
HEALTH STATUS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MENTAL HEALTH;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SOCIAL STATUS;
STEROID THERAPY;
SYMPTOM;
ARTICLE;
ATTITUDE TO HEALTH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CROSS-SECTIONAL STUDY;
DRUG COMBINATION;
MIDDLE AGED;
MULTICENTER STUDY;
PATIENT SELECTION;
PHYSIOLOGY;
PSYCHOLOGICAL ASPECT;
ADRENAL CORTEX HORMONES;
ADULT;
ATTITUDE TO HEALTH;
CROSS-SECTIONAL STUDIES;
DRUG THERAPY, COMBINATION;
FEMALE;
HEALTH STATUS;
HUMAN;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGE;
PATIENT SELECTION;
QUALITY OF LIFE;
SUPPORT, NON-U.S. GOV'T;
TACROLIMUS;
HUMANS;
MIDDLE AGED;
|
EID: 0035993698
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02984-6 Document Type: Conference Paper |
Times cited : (18)
|
References (12)
|